211735-76-1O=C(c1ccc2nonc2c1)N1CCCCC1XFVRBYKKGGDPAJ-UHFFFAOYSA-NFarampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).
211735-76-1DTXSID90175413CHEMBL1276138UsesFarampator has shown effects as an AMPA receptor potentiator and glycine reuptake inhibitor with potential anti-psychotic efficacy and enhancement of prefrontal glutamatergic transmission. Farampator’s effects on both AMPA-PAMs and GlyT-1 inhibitor maybe also improve cognitive impairments in schizophrenia and in particular when combied with Risperidone (R525000).
Loading…